CSIMarket Company Name, Ticker, Competitors, else..
Nuvectis Pharma inc   (NASDAQ: NVCT)
Other Ticker:  
 


 

Nuvectis Pharma inc

NVCT's Financial Statements and Analysis



Nuvectis Pharma inc narrowed third quarter of 2025 net loss per share of $-0.44 compare to net loss per share of $-12.00 recorded in the same quarter a year ago a decrease compare to $-0.30 realized in previous quarter.


third quarter of 2025
Earnings Per Share Revenues
$ -0.44 $  0 Mill
$+11.56     Unch.    



Nuvectis Pharma Inc 's Revenue fell by 0 % in third quarter of 2025 (Sep 30 2025) year on year, to $0 million and declined by sequentially.


Nuvectis Pharma Inc is

More on NVCT's Income Statement



Nuvectis Pharma Inc in the third quarter of 2025 recorded net loss of $-9.891 million, an increase from net loss of $-4.153 million in III. Quarter a year ago.

Sequentially net loss advanced

More on NVCT's Growth

Nuvectis Pharma Inc Inventories
NVCT's Cash flow In the third quarter of 2025 company's net cash flow was $9 million


Nuvectis Pharma inc does not pay out common stock dividend.

In trailing twelve-month period Nuvectis Pharma inc payed $ -0.64 cash per share, on a free-cash flow basis .

Book value grew by 33.83 % sequentially to $1.06 per share.
Tangible Book value grew to $ 1.06 per share from $ 0.79.

Company issued 1.35 million shares or 6.33 % in Sep 30 2025.


• More on NVCT's Dividends

 Market Capitalization (Millions) 137
 Shares Outstanding (Millions) 23
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -27
 Cash Flow (TTM) (Millions $) 18
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 13




Nuvectis Pharma inc does not pay out common stock dividend.

In trailing twelve-month period Nuvectis Pharma inc had negative $ -0.64 cash flow per share, on a free-cash flow basis .

Book value grew by 33.83 % sequentially to $1.06 per share.
Tangible Book value grew to $ 1.06 per share from $ 0.79.

Company issued 1.35 million shares or 6.33 % in Sep 30 2025.


• More on NVCT's Balance Sheets

 Market Capitalization (Millions) 137
 Shares Outstanding (Millions) 23
 Total Debt (Millions $) -
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -27
 Cash Flow (TTM) (Millions $) 18
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 13
   


  News about Nuvectis Pharma inc Earnings

Nuvectis Pharma Inc Faces Corporate Performance Reduction in First Quarter of 2024

Nuvectis Pharma Inc, a major pharmac...